|
Volumn 2, Issue 3, 1999, Pages 95-101
|
Anti-CD20 monoclonal antibodies as novel treatments for non-Hodgkin's lymphoma
a
BIOGEN
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
CHELATING AGENT;
CISPLATIN;
DIPHTHERIA TOXIN;
DOXORUBICIN;
EDETIC ACID;
ETOPOSIDE;
IBRITUMOMAB TIUXETAN;
ISOTOPE;
MONOCLONAL ANTIBODY;
PENTETIC ACID;
RICIN;
RITUXIMAB;
UNCLASSIFIED DRUG;
B CELL LYMPHOMA;
BRONCHOSPASM;
CHILL;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
FEVER;
HEADACHE;
HUMAN;
HYPOTENSION;
NAUSEA;
NONHODGKIN LYMPHOMA;
RADIOIMMUNOTHERAPY;
REVIEW;
|
EID: 0033105782
PISSN: 14615347
EISSN: None
Source Type: Journal
DOI: 10.1016/S1461-5347(99)00128-5 Document Type: Review |
Times cited : (10)
|
References (60)
|